New York · 2025 Regular Session · Bill
A 2650: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 2650 is a bill introduced in the New York House on January 21, 2025. According to its official title, it concerns: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology. Primary sponsor: Nader Sayegh (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO INSURANCE.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Nader Sayegh | Primary sponsor | Democratic | House | 90 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO INSURANCE
- REFERRED TO INSURANCE